J U Que - Concepedia

Concepedia

Author

J U Que

Swiss Vaccine Research Institute

Also Known As

J U Que, J. U. QUE, J. U. Que, J.U Que, J.U. Que, JU Que, Jianglong Que, Jing Que

35

Publications

1.3K

Citations

20

H-Index

33

Concepts

All Affiliations

Swiss Vaccine Research Institute Walter Reed Army Institute of Research University of Bern University Hospital of Bern University of Vienna

JU

About

J U Que is an author at Swiss Vaccine Research Institute specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	990
2	Health Sciences	4	4	405
3	Biochemistry	2	2	51
4	Natural Sciences	1	1	17
5	Allergy	1	1	55

J U Que

×

22

Publications

1.3K

Citations

20

H-Index

	Year	Citations
Immunogenicity of new virosome influenza vaccine in elderly people Reinhard Glück, Robert Mischler, Beatriz Finkel, The Lancet VaccinationVaccine DevelopmentElderly PeopleImmunologyInfluenza Vaccine	1994	204
Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance D. J. Hentges, April Jae Stein, S W Casey, Infection and Immunity DysbiosisColonization ResistanceAntimicrobial ChemotherapyAntibiotic ResistanceIntestinal Flora	1985	135
Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice J U Que, D. J. Hentges Infection and Immunity Colonization ResistanceAntibiotic AdjuvantImmunologyAntibiotic ResistanceDrug Resistance	1985	119
Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin J U Que, S W Casey, D. J. Hentges Infection and Immunity GastroenterologyPathologyDigestive TractDrug ResistanceDrinking Water	1986	101
Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis U. B. Schaad, J Wedgwood, Anna Ruedeberg, The Lancet VaccinationMucosal VaccinationImmunologyPseudomonas Aeruginosa ConjugateMicrobiology	1991	83
Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Stanley J. Cryz, Aloïs B. Lang, A Rüdeberg, PubMed VaccinationNon-colonized Cystic FibrosisHigh AffinityMucosal VaccinationVaccine Development	1997	55
Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A Louis Fries, D M Gordon, Imogene Schneider, Infection and Immunity Plasmodium Falciparum VaccineMalariaImmunologyImmunotherapyReverse Vaccinology	1992	53
Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine Stanley J. Cryz, E Fürer, J U Que Infection and Immunity Microbial ToxinPseudomonas Aeruginosa 3064Antimicrobial SusceptibilityHealth SciencesControlled Heating	1991	50
Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients Urs Bruderer, Stanley J. Cryz, U. B. Schaad, The Journal of Infectious Diseases	1992	49
Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa Stanley J. Cryz, J Wedgwood, Aloïs B. Lang, The Journal of Infectious Diseases	1994	46

Page 1